Blog
RSS FeedPosted by Michael Wonder on 23 Jun 2023
Changes to PBS eligibility criteria for Paxlovid
23 June 2023 - In an out of session consideration, the PBAC has recommended changes to the circumstances under which nirmatrelvir ...
Posted by Michael Wonder on 16 Jun 2023
Outcomes of the May 2023 PBAC intracycle meeting
16 June 2023 - The outcomes from the May 2023 PBAC intracycle meeting are now available. ...
Posted by Michael Wonder on 24 May 2023
Revolutionising MS treatment: new form of Tysabri recommended for PBS listing
24 May 2023 - The PBAC has recommended the listing of natalizumab (Tysabri) pre-filled syringe for subcutaneous injection on the PBS. ...
Posted by Michael Wonder on 12 May 2023
Outcome in relation to fluticasone propionate – May 2023 PBAC intracycle meeting
12 May 2023 - The outcome for fluticasone propionate from the May 2023 PBAC meeting is now available. ...
Posted by Michael Wonder on 10 May 2023
Recommendations made out-of-session by the PBAC between March 2023 and July 2023 meetings
10 May 2023 - Recommendations made out-of-session by the PBAC between its March 2023 and July 2023 meetings are now available. ...
Posted by Michael Wonder on 21 Apr 2023
Recommendations made by the PBAC (March 2023)
21 April 2023 - Recommendations made by the PBAC in March 2023 relating to the listing of medicines on the Pharmaceutical ...
Posted by Michael Wonder on 01 Apr 2023
Outcome statement - February 2023 DUSC meeting
31 March 2023 - The outcome statement from the February 2023 DUSC meeting is now available. ...
Posted by Michael Wonder on 24 Feb 2023
Recommendations made out of session by the PBAC November 2022 and March 2023 meetings
24 February 2023 - Recommendations made out of session by the PBAC between its November 2022 and March 2023 meetings are ...
Posted by Michael Wonder on 27 Jan 2023
Recommendations made by the PBAC – December 2022 intracycle meeting
27 January 2023 - Recommendations made by the PBAC in December 2022 relating to the listing of drugs on the PBS ...
Posted by Michael Wonder on 22 Dec 2022
Final report for the post-market review of medicines for smoking cessation and review outcomes
22 December 2022 - The final report for the post-market review of medicines for smoking cessation is now available. The ...
Posted by Michael Wonder on 16 Dec 2022
Recommendations made by the PBAC – November 2022
16 December 2022 - The outcomes from the November 2022 PBAC meeting are now available. ...
Posted by Michael Wonder on 24 Nov 2022
Outcome in relation to discussion of COVID-19 oral treatments – November 2022 PBAC meeting
24 November 2022 - A PBAC outcome in relation to discussion of COVID-19 oral treatments at the November 2022 meeting has ...
Posted by Michael Wonder on 03 Nov 2022
Outcome statement - September 2022 DUSC meeting
3 November 2022 - The outcome statement from the September 2022 DUSC meeting is now available. ...
Posted by Michael Wonder on 14 Oct 2022
Outcomes from the September 2022 PBAC intracycle meeting
14 October 2022 - The recommendations made by the PBAC in September 2022 relating to the listing of medicines on ...
Posted by Michael Wonder on 19 Aug 2022
Recommendations made by the PBAC - July 2022
19 August 2022 - The recommendations from the July 2022 PBAC meeting are now available. ...